Allot Ltd. Senior Vice President R&D Grossman Boaz sold 4,000 shares at $7.80 per share, leaving him with 182,000 shares after the transaction. The disclosed post-sale holding gives investors the remaining ownership figure for a senior executive following the share sale.
Key Highlights
- The transaction occurred on Aug. 28, 2026.
- Grossman Boaz serves as Allot Ltd.’s Senior Vice President R&D.
- His reported ownership after the transaction was 182,000 shares.
Allot Ltd. (NASDAQ: ALLT) Senior Vice President R&D Grossman Boaz sold 4,000 shares. The reported transaction price was $7.80 per share, and his reported ownership following the transaction was 182,000 shares.
Grossman Boaz’s Allot Share Ownership
The transaction took place on Aug. 28, 2026. Grossman Boaz holds the Senior Vice President R&D role at Allot Ltd. The filing states that he owned 182,000 shares following the transaction. That figure represents his reported ownership after the 4,000-share transaction. The transaction price was $7.80 per share. The disclosed details identify both the number of shares sold and the per-share price.
Peers Moving on This News
FAQs
Q: How many Allot Ltd. shares did Grossman Boaz sell?
A: Grossman Boaz sold 4,000 Allot Ltd. shares in the reported transaction. The Form 4 lists the sale price as $7.80 per share.
Q: How many Allot Ltd. shares does Grossman Boaz own after the sale?
A: Following the transaction, Grossman Boaz owned 182,000 Allot Ltd. shares, according to the filing. The source identifies him as Allot Ltd.’s Senior Vice President R&D.
Q: When did the Allot Ltd. executive share sale occur?
A: The Allot Ltd. executive share sale occurred on Aug. 28, 2026, according to the filing. Grossman Boaz sold 4,000 shares at $7.80 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.